You are here

SAB Biotherapeutics Reports Positive Results from COVID Drug SAB-185

Primary tabs

SAB Biotherapeutics Reports Positive Results from COVID Drug SAB-185

Wed, 2023-04-26 10:27 — mike kraft

SAB Biotherapeutics Sees Positive Results from COVID Drug SAB-185 By Exec Edge Editorial Staff SAB Biotherapeutics (Nasdaq: SABS) said it saw positive results from a Phase 3 clinical trial that assessed its Covid-19 drug, SAB-185, in non-hospitalized people who were at high-risk for severe outcomes. SAB-185 demonstrated benefit in sustained symptom resolution in study participants with Covid-19 caused by Omicron as compared to participants […] Yahoo Finance

Country / Region Tags:

General Topic Tags:

Disease Prevention

Problem, Solution, SitRep, or ?:

Situation Report

Groups this Group Post belongs to:

- Private group -

Log in or register to post comments

Workflow history

Revision ID	Field name	Date	Old state	New state name	By	Comment	Operations
			No state	No state

Page loaded in 0.474 seconds.